Vaccines and Related Biological Products Advisory Committee February 25, 2011: Vaccines and Related Biological Products Advisory Committee Meeting Draft Agenda

February 25, 2011: Vaccines and Related Biological Products Advisory Committee Meeting Draft Agenda
DoubleTree Hotel Bethesda and Executive Meeting Center
8120 Wisconsin Ave., Bethesda, MD 20814
February 25, 2011

DRAFT AGENDA
Topic: Strain Selection for the Influenza Virus Vaccine for the 2011-2012 Season

8:30 a.m. Call to Order Chair

8:35 Administrative Remarks Don Jehn, M.S., FDA

8:45 Introduction Jerry Weir, Ph.D., FDA

8:55 U.S. Surveillance Lisa Grohskopf, M.D., CDC

9:15 World Surveillance/Virus Characterization Nancy Cox, Ph.D., CDC

10:00 DoD Vaccine Effectiveness Report Kevin Russell, M.D., DOD

10:20 Break

10:35 Vaccine Responses Zhiping Ye, M.D., Ph.D., FDA

10:55 Availability of Vaccine Viruses & Reagents William McCormick, Ph.D., FDA

11:10 Comments from Manufacturers Samson Lee, Ph.D.,
Sanofi Pasteur

11:30 Update on H5N1 and H9N2 Surveillance and Virus Characterization
Nancy Cox, Ph.D., CDC

11:50 Open Public Hearing
12:50 Committee Discussion and Recommendations
1:50 Adjourn for the Day

Vaccines and Related Biological Products Advisory Committee February 25, 2011: Vaccines and Related Biological Products Advisory Committee Meeting Draft Agenda




February 25, 2011: Vaccines and Related Biological Products Advisory Committee Meeting Members, Speakers and Participant Roster
Food and Drug Administration
Center for Biologics Evaluation and Research
Vaccines and Related Biological Products Advisory Committee
February 25, 2011

Member List
Temporary Voting Members and Non Voting Member
Speakers/Participants
FDA Administrative Personnel

directory brochure:
Vaccines and Related Biological Products Advisory Committee > February 25, 2011: Vaccines and Related Biological Products Advisory Committee Meeting Members, Speakers and Participant Roster